LifeStance Health Group’s (LFST) “Outperform” Rating Reiterated at William Blair

LifeStance Health Group (NASDAQ:LFST)‘s stock had its “outperform” rating restated by research analysts at William Blair in a research note issued on Friday,RTT News reports.

Several other analysts have also recently commented on the company. Barclays boosted their price target on LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research report on Monday, November 11th. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price for the company in a research report on Monday, December 16th. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $8.70.

LifeStance Health Group Price Performance

LifeStance Health Group stock traded down $0.03 during midday trading on Friday, reaching $7.72. The company had a trading volume of 871,111 shares, compared to its average volume of 1,182,347. LifeStance Health Group has a 12-month low of $4.64 and a 12-month high of $9.00. The firm’s fifty day simple moving average is $7.79 and its 200-day simple moving average is $7.21. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The company has a market capitalization of $2.95 billion, a P/E ratio of -29.75 and a beta of 1.28.

Hedge Funds Weigh In On LifeStance Health Group

A number of hedge funds have recently made changes to their positions in the stock. Blue Trust Inc. lifted its stake in LifeStance Health Group by 124.4% during the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after purchasing an additional 2,122 shares in the last quarter. Townsquare Capital LLC purchased a new stake in LifeStance Health Group during the third quarter worth about $73,000. R Squared Ltd acquired a new stake in shares of LifeStance Health Group during the fourth quarter worth about $80,000. Ameriprise Financial Inc. acquired a new position in shares of LifeStance Health Group in the fourth quarter valued at approximately $87,000. Finally, Cibc World Markets Corp acquired a new position in shares of LifeStance Health Group in the fourth quarter valued at approximately $96,000. Hedge funds and other institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.